How CAR T Cells are Transforming Cancer Care | Dr. Stanley Riddell on Immunotherapy

In this episode of the Oncology Insights Podcast, host Dr. Petros Grivas is joined by Dr. Stanley Riddell, one of the world's leading pioneers of cancer immunotherapy and a longtime physician-scientist at Fred Hutch. Dr. Riddell's career traces the remarkable evolution of immunotherapy, from the early days of bone marrow transplantation to the development of genetically engineered T-cell therapies that are transforming cancer care today. Main Topics: Dr. Riddell's career path and contributions to immunotherapy Development and clinical success of CAR T cell therapy Challenges of translating immunotherapy from lab to clinic Future of cancer treatment and possibilities for solid tumors Collaboration between academia, industry, and global health equity The importance of perseverance and impactful research   Timestamps: 00:00 - Introduction to Dr. Stanley Riddell and his contributions to immunotherapy 02:00 - Early career: Stem cell transplant and immunology breakthroughs 05:00 - Overcoming infectious complications in transplant patients 08:00 - Development of CMV-specific T cells and initial cancer applications 11:00 - The birth and growth of CAR T cell therapy at Fred Hutch 12:50 - Clinical successes and ongoing challenges in CAR T treatments 15:00 - Industry collaborations and commercialization efforts 16:00 - Implementing CAR T therapies in community settings and future innovations 18:00 - Addressing healthcare disparities globally 20:00 - The infrastructure at Fred Hutch supporting cutting-edge research 23:00 - The promising future of biomedical science and immunology 25:00 - Role of funding and federal support in sustaining innovation 26:00 - Potential of immunotherapy in solid tumors and personalized medicine 28:00 - Final thoughts: hope for curing more patients and improving quality of life   Resources & Links: Stan Riddell Faculty Bio: https://www.fredhutch.org/en/faculty-lab-directory/riddell-stanley.html